Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7

被引：1
|
作者：
Chen, Zhi-Ting [1 ,2 ]
Zhao, Zhen-Hua [2 ,3 ]
Chen, Li-Na [1 ,2 ]
Fan, Fei [4 ]
Cai, Guo-En [1 ,2 ]
Weng, Hui-Dan [1 ,2 ]
Wang, Ying-Qing [1 ,2 ]
Liao, Lian-Ming [5 ]
Chen, Xiao-Chun [2 ]
Huang, En [6 ]
Ye, Qin-Yong [1 ,2 ]
机构：
[1] Fujian Med Univ, Fujian Inst Geriatr, Dept Neurol, Union Hosp, Fuzhou 350001, Peoples R China
[2] Fujian Med Univ, Inst Neurosci, Fujian Key Lab Mol Neurol, Fuzhou 350001, Peoples R China
[3] Fujian Med Univ, Shengli Clin Med Coll, Fuzhou 350001, Peoples R China
[4] Fujian Hlth Coll, Fuzhou 350101, Peoples R China
[5] Fujian Med Univ, Ctr Translat Med Hematol, Union Hosp, Fuzhou 350001, Peoples R China
[6] Fujian Med Univ, Sch Basic Med Sci, Fuzhou 350122, Peoples R China
来源：
STEM CELL RESEARCH | 2021年 / 51卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.scr.2021.102175
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
PARK7 mutations are accountable for the inherited Parkinson's disease. An induced pluripotent stem cell (iPSC) line FJMUUHi001-A was generated by expressing five reprogramming factors, OCT3/4, SOX2, c-MYC, KLF4 and BCL-XL, in peripheral blood mononuclear cells from a 32-year old patient carrying a homozygous mutation of c.189dupA in PARK7. The iPSCs with a normal karyotype had the abilities to differentiate into three germ layers and expressed pluripotency markers without detectable residual plasmids. The cell line FJMUUHi001-A carrying the truncating protein PARK7 could be a useful tool to help comprehend the function of PARK7 in the iPSCs and differentiated cells from them.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Generation of an induced pluripotent stem cell line (CHFUi001-A) from an osteogenesis imperfecta patient with COL1A2 mutation
    Zheng, Zhangqian
    Lu, Wei
    Pei, Zhou
    Chen, Jun
    Yang, Tong
    Luo, Feihong
    STEM CELL RESEARCH, 2020, 47
  • [32] Generation of an induced pluripotent stem cell line (CSBZZUi001-A) from a female Alzheimer's patient carrying the PSEN1 709 T > C heterozygous mutation
    Meng, Xiao-Yan
    Sun, Hui-Fang
    Zhang, Ying-Jie
    Li, Wen-Xiu
    Wang, Dian -Dian
    Liu, Dan-Hua
    Li, Sen-Miao
    Wu, Yue
    Li, Jia-Kang
    Liu, Xiao-Hui
    Liu, Pei -Pei
    Yang, Run-Zhou
    Li, Shu-Ang
    Kang, Jian-Sheng
    STEM CELL RESEARCH, 2024, 79
  • [33] Establishment and characterization of human induced pluripotent stem cell line from a Parkinson's disease patient harboring VPS13A gene mutation
    Lu, Xianjie
    Wang, Wei
    Liu, Yanming
    Song, Na
    Li, Mengpeng
    Mu, Xin
    Zhang, Nan
    Chen, Qingfa
    Jiang, Licheng
    Kong, Xianglin
    Sun, Peng
    Tong, Jiabei
    Zhang, Yunping
    Li, Jingtao
    Ma, Shengjun
    Han, Fabin
    STEM CELL RESEARCH, 2022, 60
  • [34] Generation of Parkinson's disease patient-derived human induced pluripotent stem cells line (PNUSCRi001-A) carrying a N227S mutation in GBA gene
    Lee, Nayeon
    Moon, Hye-Ji
    Park, So-Hyun
    Moon, Ji-Young
    Park, Ka-Kyung
    Kim, Jae-Ho
    Lee, Jae-Hyeok
    STEM CELL RESEARCH, 2022, 65
  • [35] Generation of a human induced pluripotent stem cell line (SDUBMSi001-A) from a hereditary spastic paraplegia patient carrying kif1a c.773C>T missense mutation
    Wang Xiaojing
    Ma Yanyan
    Duan Ruonan
    Liu Xiaolin
    Zhang Haiyan
    Ma Jian
    Liu Yi
    Sun Wenjie
    Liu Qiji
    STEM CELL RESEARCH, 2020, 43
  • [36] Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p.D620N mutation in VPS35
    Larsen, Simone B.
    Hanss, Zoe
    Cruciani, Gerald
    Massart, Francois
    Barbuti, Peter A.
    Mellick, George
    Kruger, Rejko
    STEM CELL RESEARCH, 2020, 45
  • [37] Generation of an Induced Pluripotent Stem Cell Line TNRMCi001-A by Reprogramming Fibroblasts from a Homozygous F508del Cystic Fibrosis Patient
    Zhigalina, D. I.
    Kireeva, T. N.
    Nikitina, T. V.
    Odinokova, O. N.
    Kolesnikov, N. A.
    Malakhova, A. A.
    Savchenko, R. R.
    Zhalsanova, I. Zh.
    Valiahmetov, N. R.
    Postrigan, A. E.
    Vovk, S. L.
    Torkhova, N. B.
    Frolova, A. A.
    Stepanov, V. A.
    Skryabin, N. A.
    RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY, 2023, 54 (SUPPL 1) : S68 - S74
  • [38] Generation of an Induced Pluripotent Stem Cell Line TNRMCi001-A by Reprogramming Fibroblasts from a Homozygous F508del Cystic Fibrosis Patient
    D. I. Zhigalina
    T. N. Kireeva
    T. V. Nikitina
    O. N. Odinokova
    N. A. Kolesnikov
    A. A. Malakhova
    R. R. Savchenko
    I. Zh. Zhalsanova
    N. R. Valiahmetov
    A. E. Postrigan
    S. L. Vovk
    N. B. Torkhova
    A. A. Frolova
    V. A. Stepanov
    N. A. Skryabin
    Russian Journal of Developmental Biology, 2023, 54 : S68 - S74
  • [39] Generation of human induced pluripotent stem cell line FDCHDPi001-A from a Chinese Han Tourette's syndrome patient
    Yuan, Aihua
    Tao, Ran
    Yu, Shunying
    Jing, Naihe
    Sun, Jinhua
    STEM CELL RESEARCH, 2021, 52
  • [40] Generation of induced pluripotent stem cell line (ZZUi027-A) derived from skin fibroblasts from a Parkinson's disease patient with RAB39B gene mutation
    Sun, Huifang
    Wang, Zhuoya
    Zhang, Qi
    Liu, Yutao
    Yang, Jing
    Liu, Han
    Shi, Changhe
    Wang, Yanlin
    Xu, Yuming
    STEM CELL RESEARCH, 2021, 55
12345